[1]
Dunn D.W., Buelow J.M., Austin J.K. et al.: Development of syndrome
severity scores for pediatric epilepsy. Epilepsia 2004; 45: 661-666.
[2]
Kwan P., Brodie M.J.: Early identification of refractory epilepsy. N.Engl.
J.Med., 2000; 342: 314-319.
[3]
Guerreiro C.A.M.: Guidelines for drug treatment of epilepsy. Arq.
Neuropsiquiatr., 2008; 66: 591-599.
[4]
Shih J.J., Ochoa J.G.: A systematic review of antiepileptic drug initiation
and withdrawal. Neurologist 2009; 15: 122-131.
[5]
Aylward R.L.M.: Epilepsy: a review of reports, guidelines,
recommendations and models for the provision of care for patients with
epilepsy. Clin.Med. 2008; 8: 433-438.
[6]
Azar N.J., Abou-Khalil B.W.: Considerations in the choice of an
antiepileptic drug in the treatment of epilepsy. Semin Neurol., 2008; 28:
305-316.
[7]
Glauser T., Ben-Menachem E., Bourgeois B. et al.: ILAE treatment
guidelines: evidence-based analysis of antiepileptic drug efficacy
and effectiveness as initial monotherapy for epileptic seizures and
syndromes. Epilepsia, 2006; 47: 1094-1020.
[8]
French J.A., Kanner A.M., Bautista J. et al.: Efficacy and tolerability of the
new antiepileptic drugs I. Treatment of new onset epilepsy. Neurology
2004; 62: 1252-1260.
[9]
French J.A., Kanner A.M., Bautista J. et al.: Efficacy and tolerability of the
new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology
2004; 62: 1261-1273.
[10]
Newer drugs for epilepsy in children. National Institute for Clinical
Excellence, 2004; updated 30 March 2010. Address: http:// www.nice.
org.uk/TA079guidance
[11]
Wheless J.W., Clarke D.F., Carpenter D.: Treatment of pediatric epilepsy:
expert opinion. J.Child Neurol., 2005; 20: S1-S56.
[12]
Wheless J.W., Clarke D.F., Arzimanoglou A. et al.: Treatment of pediatric
epilepsy: European expert opinion. Epileptic Disord., 2007; 9: 353-412.
[13]
Guerreiro M.M., Vigonius U., Pohlmann H. et al.: A double blind
controlled clinical trial of oxcarbazepine versus phenytoin in children and
adolescents with epilepsy. Epilepsy Res., 1997; 27: 205-213.
[14]
Stein M.A., Kanner A.M.: Management of newly diagnosed epilepsy: a
practical guide to monotherapy. Drugs 2009; 69: 199-222.